resources
From continuing education to podcasts by our team of experts, keep up with the latest at Children's Health.
Nephrology
Primary hyperoxaluria type 1 (PH1) is a rare genetic disorder that causes excess oxalate, leading to kidney failure and systemic damage. While liver transplant is the only cure, FDA-approved therapies are making kidney-only transplants a viable option.
Nephrology, +1 more
Children’s Health Solid Organ Transplant Center is among a select few in the nation using machine perfusion to perform heart and liver transplants. Our transplant experts share insights into this innovative technology.
Nephrology
Children’s Health spearheaded a new standard of care to improve outcomes for pediatric dialysis patients.
Nephrology
Glofil tests and DEXA scans are typically conducted by the radiology department. We house them together in our nephrology department, where experts help referring physicians understand and act on results.
Nephrology
Children’s Health℠ has one of the world's largest pediatric hemodialysis centers, and we have a comprehensive approach to helping children cope with psychosocial impacts.
Nephrology
When UT Southwestern researchers discovered that the stroma plays a key role in kidney development, it marked important progress toward understanding one of the body’s most complicated organs.
Nephrology
At Children’s Health, nephrologists, urologists and others work together to solve the mysteries of why some kids form kidney stones and how best to treat them.
Nephrology
See how the Nephrology and Neonatology Departments at Children’s Health partnered to offer advanced renal therapies for newborns and infants in the NICU.
Nephrology
A Phase 3 Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Chronocort in the Treatment of Participants Aged 16 Years and Over with Congenital Adrenal Hyperplasia.
Nephrology
To assess the effects of therapy with FC on iFGF23 levels
Nephrology
PRoMPT BOLUS is a clinical trial to compare two IV fluid treatments for pediatric sepsis.
Nephrology
This study is to evaluate the safety, efficacy and pharmacokinetics of paricalcitol oral solution in pediatric participants of ages 0 to 9 years with SHPT associated with stage 5 CKD receiving Peritoneal Dialysis (PD) or Hemodialysis (HD).
resources
From continuing education to podcasts by our team of experts, keep up with the latest at Children's Health.